15.62
price down icon0.22%   -0.02
 
loading
Precedente Chiudi:
$15.60
Aprire:
$15.52
Volume 24 ore:
635.84K
Relative Volume:
0.20
Capitalizzazione di mercato:
$4.03B
Reddito:
$6.41B
Utile/perdita netta:
$1.30B
Rapporto P/E:
3.0992
EPS:
5.04
Flusso di cassa netto:
$646.00M
1 W Prestazione:
+1.67%
1M Prestazione:
+0.48%
6M Prestazione:
-20.14%
1 anno Prestazione:
-14.95%
Intervallo 1D:
Value
$15.45
$15.65
Intervallo di 1 settimana:
Value
$15.30
$15.88
Portata 52W:
Value
$13.87
$23.10

Organon Co Stock (OGN) Company Profile

Name
Nome
Organon Co
Name
Telefono
551-430-6000
Name
Indirizzo
30 HUDSON STREET, JERSEY CITY
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
OGN's Discussions on Twitter

Confronta OGN con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - General icon
OGN
Organon Co
15.62 4.03B 6.41B 1.30B 646.00M 5.04
Drug Manufacturers - General icon
LLY
Lilly Eli Co
841.61 754.10B 45.04B 10.59B 414.30M 11.71
Drug Manufacturers - General icon
ABBV
Abbvie Inc
210.01 374.57B 56.33B 4.28B 17.83B 2.40
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
76.93 338.61B 42.09B 14.65B 10.11B 3.2833
Drug Manufacturers - General icon
JNJ
Johnson Johnson
163.46 344.63B 88.82B 14.07B 18.06B 5.79
Drug Manufacturers - General icon
MRK
Merck Co Inc
93.41 238.10B 64.17B 17.12B 18.10B 6.73

Organon Co Stock (OGN) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-09-06 Downgrade JP Morgan Neutral → Underweight
2023-11-03 Downgrade Goldman Buy → Neutral
2023-09-21 Iniziato Barclays Overweight
2023-03-16 Iniziato Raymond James Outperform
2022-10-14 Downgrade BofA Securities Neutral → Underperform
2022-09-06 Aggiornamento Piper Sandler Neutral → Overweight
2022-08-05 Downgrade BofA Securities Buy → Neutral
2022-04-27 Iniziato Goldman Buy
2022-04-06 Ripresa Morgan Stanley Equal-Weight
2021-10-07 Iniziato Piper Sandler Neutral
2021-09-01 Iniziato BofA Securities Buy
2021-07-22 Iniziato Citigroup Buy
2021-06-15 Iniziato JP Morgan Neutral
2021-06-11 Iniziato Morgan Stanley Equal-Weight
2021-06-10 Iniziato Evercore ISI Outperform
Mostra tutto

Organon Co Borsa (OGN) Ultime notizie

pulisher
Mar 19, 2025

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Mar 19, 2025
pulisher
Mar 19, 2025

Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune

Mar 19, 2025
pulisher
Mar 19, 2025

Organon (OGN) Advances While Market Declines: Some Information for Investors - MSN

Mar 19, 2025
pulisher
Mar 17, 2025

Why Organon Is A Top Pick For Income Investors (NYSE:OGN) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 14, 2025

Is Organon & Co. (OGN) the Deep Value Stock to Buy Now? - Insider Monkey

Mar 14, 2025
pulisher
Mar 14, 2025

Organon & Co. (NYSE:OGN) Receives $20.80 Consensus Target Price from Analysts - Defense World

Mar 14, 2025
pulisher
Mar 13, 2025

Organon & Co. (NYSE:OGN) Shares Sold by US Bancorp DE - Defense World

Mar 13, 2025
pulisher
Mar 13, 2025

Organon & Co (OGN) Trading Down 2.88% on Mar 12 - GuruFocus.com

Mar 13, 2025
pulisher
Mar 13, 2025

Organon’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 12, 2025

Organon’s SWOT analysis: stock poised for growth amid challenges - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

Trend Tracker for (OGN) - Stock Traders Daily

Mar 12, 2025
pulisher
Mar 11, 2025

Proficio Capital Partners LLC Acquires New Holdings in Organon & Co. (NYSE:OGN) - Defense World

Mar 11, 2025
pulisher
Mar 10, 2025

Healthcare Veteran Appointed CEO of May Health's Groundbreaking PCOS Technology - StockTitan

Mar 10, 2025
pulisher
Mar 10, 2025

New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older - BioSpace

Mar 10, 2025
pulisher
Mar 10, 2025

MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO - Quantisnow

Mar 10, 2025
pulisher
Mar 09, 2025

Organon announes results from analysis of Phase 3 ADORING 3 study - TipRanks

Mar 09, 2025
pulisher
Mar 08, 2025

Can This Skin Treatment Work for Months After Stopping? New Clinical Data Reveals Surprising Results - StockTitan

Mar 08, 2025
pulisher
Mar 07, 2025

Organon and Partners Advance Women’s Health Innovation to Drive Economic and Social Growth in Southeast Asia - The Hastings Tribune

Mar 07, 2025
pulisher
Mar 07, 2025

Organon and partners drive innovation to strengthen healthcare access - Bangkok Post

Mar 07, 2025
pulisher
Mar 06, 2025

Organon & Co. (NYSE:OGN) Shares Sold by Private Advisor Group LLC - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Truist Financial Corp Increases Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World

Mar 05, 2025
pulisher
Mar 01, 2025

(OGN) Long Term Investment Analysis - Stock Traders Daily

Mar 01, 2025
pulisher
Mar 01, 2025

Principal Financial Group Inc. Raises Stock Position in Organon & Co. (NYSE:OGN) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

New York State Common Retirement Fund Buys 43,928 Shares of Organon & Co. (NYSE:OGN) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Organon & Co. (NYSE:OGN) Shares Up 5.7%Here's What Happened - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

A&I Financial Services LLC Invests $402,000 in Organon & Co. (NYSE:OGN) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

Is Organon & Co. (OGN) the Best Low Price Pharma Stock to Invest In Right Now? - Insider Monkey

Feb 27, 2025
pulisher
Feb 26, 2025

Rhumbline Advisers Sells 14,051 Shares of Organon & Co. (NYSE:OGN) - Defense World

Feb 26, 2025
pulisher
Feb 25, 2025

Principal Financial Group Inc. Buys 32,485 Shares of Organon & Co. (NYSE:OGN) - Defense World

Feb 25, 2025
pulisher
Feb 23, 2025

The Hidden Gems of the Pharma World: Stocks Analysts Can’t Ignore - jomfruland.net

Feb 23, 2025
pulisher
Feb 22, 2025

Organon & Co. (OGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey

Feb 22, 2025
pulisher
Feb 22, 2025

10 Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey

Feb 22, 2025
pulisher
Feb 21, 2025

Allspring Global Investments Holdings LLC Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

New York State Teachers Retirement System Has $4.61 Million Holdings in Organon & Co. (NYSE:OGN) - Defense World

Feb 21, 2025
pulisher
Feb 20, 2025

Savant Capital LLC Sells 88,315 Shares of Organon & Co. (NYSE:OGN) - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Organon's SWOT analysis: women's health leader faces biosimilar growth, LOE challenges - MSN

Feb 20, 2025
pulisher
Feb 19, 2025

Organon announces departure of chief commercial officer - MSN

Feb 19, 2025
pulisher
Feb 19, 2025

Philip James Wealth Mangement LLC Has $12.99 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat

Feb 19, 2025

Organon Co Azioni (OGN) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$105.19
price down icon 1.99%
drug_manufacturers_general SNY
$57.41
price down icon 0.69%
drug_manufacturers_general PFE
$26.04
price down icon 0.57%
$312.14
price down icon 1.03%
drug_manufacturers_general NVS
$113.13
price down icon 0.18%
drug_manufacturers_general MRK
$94.45
price down icon 0.56%
Capitalizzazione:     |  Volume (24 ore):